Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study

Shah, N. N., Wang, M. L., Brown, J. R., Patel, K., Woyach, J. A., Wierda, W. G., Ujjani, C. S., Eyre, T. A., Zinzani, P. L., Alencar, A. J., Gastinne, T., Ghia, P., Lamanna, N., Hoffmann, M., Patel, M. R., Flinn, I. W., Gerson, J. N., Ma, S., Coombs, C. C., … Mato, A. R. (2022). Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study. Blood, 140(Supplement 1), 4127–4132. https://doi.org/10.1182/blood-2022-159035
Authors:
Nirav N. Shah
Michael Wang
Jennifer R. Brown
Krish Patel
Jennifer A. Woyach
William G. Wierda
Chaitra S. Ujjani
Toby A. Eyre
Pier Luigi Zinzani
Alvaro J. Alencar
Thomas Gastinne
Paolo Ghia
Nicole Lamanna
Marc Hoffmann
Manish R. Patel
Ian W. Flinn
James N. Gerson
Shuo Ma
Catherine C. Coombs
Chan Y. Cheah
Ewa Lech‐Marańda
Bita Fakhri
Won-Seog Kim
Minal Barve
Jonathon B. Cohen
Wojciech Jurczak
Talha Munir
Meghan C. Thompson
Lindsey E. Roeker
Katherine Bao
Nicholas A. Cangemi
Jennifer Kherani
Richard A. Walgren
Hong‐Mei Han
Amy S. Ruppert
Anthony R. Mato
Affiliated Authors:
Jennifer A. Woyach
Nicole Lamanna
Columbia Affiliation:
Subjects:
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (OpenAlex Topic)
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2022-159035
DOI:
10.1182/blood-2022-159035
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: